Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients?
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Researchers from Memorial Sloan-Kettering Cancer Center, in collaboration with The New York
Presbyterian Hospital-Weill Medical College of Cornell University, are conducting a study of
a medicinal mushroom extract called Maitake (pronounced my-tock-e).
Laboratory studies show that Maitake can reduce the growth of cancer in animals. The Maitake
does not kill cancer cells directly. It is believed to work through the immune system (the
body's defense system against infection). Our test tube, animal and human dose determining
studies show that Maitake can enhance immune function. We are conducting this study to see
whether Maitake improves the neutrophil count and function in patients with MDS. The
neutrophils are white blood cells which help to fight infection.
Phase:
Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborators:
Weill Medical College of Cornell University YUKIGUNI COMPANY